Curis (CRIS) EBIT Growth (3y) (2013 - 2026)
Curis (CRIS) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
0.31% |
| Date | Value |
|---|
| Mar 31, 2026 |
0.31% |
| Dec 31, 2025 |
57.67% |
| Sep 30, 2025 |
18.10% |
| Jun 30, 2025 |
18.18% |
| Mar 31, 2025 |
12.45% |
| Dec 31, 2024 |
10.55% |
| Sep 30, 2024 |
-1.69% |
| Jun 30, 2024 |
-5.52% |
| Mar 31, 2024 |
-12.32% |
| Dec 31, 2023 |
-24.81% |
| Sep 30, 2023 |
-37.95% |
| Jun 30, 2023 |
-30.75% |
| Mar 31, 2023 |
-11.09% |
| Dec 31, 2022 |
-11.70% |
| Sep 30, 2022 |
-33.29% |
| Jun 30, 2022 |
-34.86% |
| Mar 31, 2022 |
-39.64% |
| Dec 31, 2021 |
-34.65% |
| Sep 30, 2021 |
-16.12% |
| Jun 30, 2021 |
-10.66% |
